Levosalbutamol in pharma franchise in Sikkim

Levosalbutamol in PCD pharma franchise in Shillong

Levosalbutamol in top pharma company in Kanpur

Levosalbutamol in pcd pharma supplier in Pimpri-Chinchwad

Levosalbutamol in phama franchise company in India
Levosalbutamol in phama distributor in Vadodara

Home/Products /levosalbutamol-0-point-31mg-respules

Critsal 0.31 Respule

Composition : Levosalbutamol (0.31mg) Respule

Dosage Form : Respule

Packaging Type : Pack

Packaging : 4x5x2.5ml

Price : ₹73.75/-

Critsal 0.31 Respule is a specialized respiratory medication containing Levosalbutamol (0.31mg). It is designed to provide effective relief from bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol, a short-acting beta-agonist (SABA), works by relaxing the muscles in the airways, thereby improving airflow and easing breathing. This makes it particularly beneficial for managing acute asthma attacks and respiratory conditions associated with airway obstruction.

The respule form allows for administration through nebulization, ensuring direct delivery of the medication to the lungs for rapid and targeted action. It is especially suitable for individuals who have difficulty using inhalers, such as young children or elderly patients. Critsal 0.31 Respule helps alleviate symptoms like wheezing, shortness of breath, and chest tightness, enabling better respiratory function and improving the quality of life.

Read More

About the Product

Critsal 0.31 Respule is a specialized respiratory medication containing Levosalbutamol (0.31mg). It is designed to provide effective relief from bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol, a short-acting beta-agonist (SABA), works by relaxing the muscles in the airways, thereby improving airflow and easing breathing. This makes it particularly beneficial for managing acute asthma attacks and respiratory conditions associated with airway obstruction.

The respule form allows for administration through nebulization, ensuring direct delivery of the medication to the lungs for rapid and targeted action. It is especially suitable for individuals who have difficulty using inhalers, such as young children or elderly patients. Critsal 0.31 Respule helps alleviate symptoms like wheezing, shortness of breath, and chest tightness, enabling better respiratory function and improving the quality of life.

May cause mild tremors, headache, palpitations, or throat irritation. Serious side effects are rare.

Indicated for the treatment and prevention of bronchospasm in asthma and COPD.

Use under medical supervision. Follow the prescribed dosage and consult your doctor if symptoms persist or worsen.

Store below 25°C in a cool, dry place. Protect from light and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation